Formononetin ameliorates IL‑13‑induced inflammation and mucus formation in human nasal epithelial cells by activating the SIRT1/Nrf2 signaling pathwayJuanjuan Huang(Ningbo University), Aihua Xie(Guangzhou University of Chinese Medicine)Molecular Medicine ReportsSeptember 30, 202110.3892/mmr.2021.12472Cited by 26SaveCiteExport RISWatch citationsRelated PapersFinal overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)|Annals of Oncology|2015|467